• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNA引发E和NS1构建体——同源蛋白增强免疫策略以改善小鼠对登革热的免疫反应。

DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.

作者信息

Mellado-Sánchez Gabriela, García-Cordero Julio, Luria-Pérez Rosendo, Lázaro-Olan Lucero, Santos-Argumedo Leopoldo, Gutiérrez-Castañeda Benito, Estrada-García Iris, Cedillo-Barrón Leticia

机构信息

Departamento de Biomedicina Molecular Centro de Investigación y Estudios Avanzadas del IPN, Mexico, DF Mexico.

出版信息

Viral Immunol. 2005;18(4):709-21. doi: 10.1089/vim.2005.18.709.

DOI:10.1089/vim.2005.18.709
PMID:16359237
Abstract

DNA priming-protein boosting is a strategy used to establish strong immunity to a specific pathogen by the use of two different antigens through sequential delivery systems. In this work, two recombinant plasmids were used, one encoding for the dengue virus E protein, which is know to induce neutralizing antibodies (pcDNA 3.1/E), and the other encoding for the Dengue virus nonstructural protein 1 (pcDNA 3.1/NS1), as a source of B- and T-cell epitopes possibly involved in protective immunity. We showed that immunization of BALB/c mice with three priming doses of both plasmids pcDNA 3.1/E and/or pcDNA 3.1/NS1 were able to induce antibody responses to E protein with a single plasmid; in contrast to the antibody response to NS1 protein we observed an additive effect in terms of antibody response. Moreover, using a prime-boost protocol in which both plasmid constructs were co-administrated followed by a boost of homologous GST-E and GST-NS1 recombinant proteins, we observed an increased antibody response to NS1 and to E protein compared to animals vaccinated with the proteins or with dengue constructs alone. If neutralizing antibodies play an important role in dengue infection, antibodies generated with this regimen was also significantly better than the administration of the mix of proteins alone. These results suggest that NS1 and E proteins together could be considered in a design of subunit recombinant vaccines.

摘要

DNA 初免-蛋白加强免疫是一种通过使用两种不同抗原经序贯递送系统来建立针对特定病原体的强大免疫力的策略。在本研究中,使用了两种重组质粒,一种编码登革病毒 E 蛋白(已知其可诱导中和抗体,即 pcDNA 3.1/E),另一种编码登革病毒非结构蛋白 1(pcDNA 3.1/NS1),后者作为可能参与保护性免疫的 B 细胞和 T 细胞表位的来源。我们发现,用 pcDNA 3.1/E 和/或 pcDNA 3.1/NS1 这两种质粒的三个初免剂量免疫 BALB/c 小鼠,能够用单个质粒诱导针对 E 蛋白的抗体反应;与针对 NS1 蛋白的抗体反应不同,我们在抗体反应方面观察到了累加效应。此外,采用一种初免-加强方案,即同时给予两种质粒构建体,随后用同源的 GST-E 和 GST-NS1 重组蛋白进行加强免疫,我们观察到与单独用这些蛋白或登革构建体免疫的动物相比,针对 NS1 和 E 蛋白的抗体反应有所增强。如果中和抗体在登革热感染中起重要作用,那么用该方案产生的抗体也明显优于单独给予蛋白混合物。这些结果表明,在亚单位重组疫苗的设计中可以考虑将 NS1 和 E 蛋白结合起来。

相似文献

1
DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.DNA引发E和NS1构建体——同源蛋白增强免疫策略以改善小鼠对登革热的免疫反应。
Viral Immunol. 2005;18(4):709-21. doi: 10.1089/vim.2005.18.709.
2
A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.一种编码登革病毒 E 和 NS1 蛋白部分的质粒在小鼠模型中诱导免疫反应。
Arch Virol. 2010 Jun;155(6):847-56. doi: 10.1007/s00705-010-0652-x.
3
Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.初步评估编码登革热 2 型前膜/包膜和 NS1 的 DNA 疫苗候选物:它们在小鼠中的免疫原性和保护效力。
Mol Immunol. 2013 Jun;54(2):109-14. doi: 10.1016/j.molimm.2012.11.007. Epub 2012 Dec 25.
4
DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice.基于非结构蛋白1(ns1)基因的登革病毒DNA疫苗:不同信号序列对蛋白表达的影响及其与小鼠体内引发的免疫反应的相关性
Virology. 2007 Feb 20;358(2):413-23. doi: 10.1016/j.virol.2006.08.052. Epub 2006 Oct 3.
5
Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes.用编码病毒前膜和包膜基因的质粒DNA疫苗对恒河猴进行登革2型病毒疫苗接种。
Am J Trop Med Hyg. 2003 Apr;68(4):469-76.
6
Enhanced immune response by amphotericin B following NS1 protein prime-oral recombinant Salmonella vaccine boost vaccination protects mice from dengue virus challenge.在NS1蛋白初免-口服重组沙门氏菌疫苗加强免疫后,两性霉素B增强免疫反应可保护小鼠免受登革病毒攻击。
Vaccine. 2006 Jul 26;24(31-32):5852-61. doi: 10.1016/j.vaccine.2006.04.066. Epub 2006 May 16.
7
Production of anti-dengue NS1 monoclonal antibodies by DNA immunization.通过DNA免疫制备抗登革热NS1单克隆抗体。
J Virol Methods. 2003 Apr;109(1):55-61. doi: 10.1016/s0166-0934(03)00045-4.
8
T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.基于登革热病毒 2 型 E 和 NS1 蛋白的 DNA 疫苗在小鼠中诱导的 T 细胞反应:在保护和免疫显性表位鉴定中的重要性。
Front Immunol. 2019 Jul 3;10:1522. doi: 10.3389/fimmu.2019.01522. eCollection 2019.
9
Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.登革热和 Zika 病毒结构域 III-鞭毛蛋白融合和糖基掩蔽 E 抗原用于初次-加强免疫。
Theranostics. 2019 Jul 9;9(16):4811-4826. doi: 10.7150/thno.35919. eCollection 2019.
10
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence.用编码与组织纤溶酶原激活剂信号序列融合的非结构1(NS1)基因的DNA质粒免疫小鼠后诱导产生的对2型登革病毒的保护作用。
Vaccine. 2006 Jan 12;24(2):195-205. doi: 10.1016/j.vaccine.2005.07.059. Epub 2005 Aug 8.

引用本文的文献

1
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future.登革热及其他蚊媒黄病毒核酸疫苗的研发:过去、现在与未来。
Front Immunol. 2025 Jan 7;15:1475886. doi: 10.3389/fimmu.2024.1475886. eCollection 2024.
2
'Mix and Match' vaccination: Is dengue next?“混搭”接种疫苗:下一个是登革热吗?
Vaccine. 2022 Oct 26;40(45):6455-6462. doi: 10.1016/j.vaccine.2022.09.007. Epub 2022 Oct 1.
3
Dengue Virus and Vaccines: How Can DNA Immunization Contribute to This Challenge?
登革病毒与疫苗:DNA免疫如何应对这一挑战?
Front Med Technol. 2021 Apr 12;3:640964. doi: 10.3389/fmedt.2021.640964. eCollection 2021.
4
Long-Term Protection Elicited by a DNA Vaccine Candidate Expressing the prM-E Antigen of Dengue Virus Serotype 3 in Mice.DNA 疫苗候选物表达登革病毒 3 型 prM-E 抗原在小鼠中诱导的长期保护作用。
Front Cell Infect Microbiol. 2020 Mar 17;10:87. doi: 10.3389/fcimb.2020.00087. eCollection 2020.
5
Humanized Mice in Dengue Research: A Comparison with Other Mouse Models.登革热研究中的人源化小鼠:与其他小鼠模型的比较
Vaccines (Basel). 2020 Jan 22;8(1):39. doi: 10.3390/vaccines8010039.
6
Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.登革热病毒抗体对寨卡病毒的交叉反应、增强和中和活性:墨西哥人群的研究。
J Immunol Res. 2019 Sep 2;2019:7239347. doi: 10.1155/2019/7239347. eCollection 2019.
7
Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?互补型初免-加强免疫策略能否成为抗登革病毒的一种替代且有前景的疫苗接种方法?
Front Immunol. 2019 Aug 27;10:1956. doi: 10.3389/fimmu.2019.01956. eCollection 2019.
8
Mouse models to study dengue virus immunology and pathogenesis.用于研究登革病毒免疫学和发病机制的小鼠模型。
Front Immunol. 2014 Apr 10;5:151. doi: 10.3389/fimmu.2014.00151. eCollection 2014.
9
Animal models of dengue virus infection.登革热病毒感染的动物模型。
Viruses. 2012 Jan;4(1):62-82. doi: 10.3390/v4010062. Epub 2012 Jan 9.
10
Virus-specific cytolytic antibodies to nonstructural protein 1 of Japanese encephalitis virus effect reduction of virus output from infected cells.针对日本脑炎病毒非结构蛋白1的病毒特异性溶细胞抗体可减少受感染细胞的病毒释放量。
J Virol. 2009 May;83(10):4766-77. doi: 10.1128/JVI.01850-08. Epub 2009 Mar 4.